Tarcine BioMed Inc. has successfully obtained funding support for the 2023 Beijing High-tech Enterprise "Small Upscale" Cultivation Project

发布时间：2023-08-10 浏览次数：284次 作者：

According to several measures released by Beijing regarding the implementation of the "Three Major Projects" to further support and serve the development of high-tech enterprises. One of them is to promote a group of small and medium-sized national high-tech enterprises with high technological content and high growth potential to accelerate their sustained innovation capabilities and certain economies of scale, forming a viable force to promote high-quality economic development in the city. Each district and Beijing Economic and Technological Development Zone will select and recommend qualified national high-tech enterprises, forming a unified "small upgrade plan" for high-tech enterprises in the city Cultivation checklist. Provide financial support to enterprises newly included in the "small upgrade plan" cultivation list.

Recently, Tarcine BioMed Inc., a subsidiary of Baheal Biodiagnostics, successfully received funding support for the 2023 Beijing High tech Enterprise "Small Upscale" Cultivation Project.

This recognition fully demonstrates the recognition by the government and industry authorities of Tarcine in terms of its comprehensive strength in enterprise innovation ability, professional level, technological research and development, product services, and development potential.

In the future, Tarcine will continue to uphold the development concept of keeping up with the times and constantly innovating, forge ahead, continuously strengthen the construction of enterprise innovation capabilities, improve the core competitiveness of the enterprise, and continuously contribute to the transformation of achievements in the early diagnosis technology application platform for major human diseases.